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Available online 30 November 2016Saposin deﬁciency is a childhood neurodegenerative lysosomal storage disorder (LSD) that can cause premature
death within three months of life. Saposins are activator proteins that promote the function of lysosomal hydro-
lases that mediate the degradation of sphingolipids. There are four saposin proteins in humans, which are
encoded by the prosaposin gene. Mutations causing an absence or impaired function of individual saposins or
the whole prosaposin gene lead to distinct LSDs due to the storage of different classes of sphingolipids. The path-
ological events leading to neuronal dysfunction induced by lysosomal storage of sphingolipids are as yet poorly
deﬁned. We have generated and characterised a Drosophilamodel of saposin deﬁciency that shows striking sim-
ilarities to the human diseases. Drosophila saposin-related (dSap-r) mutants show a reduced longevity, progres-
sive neurodegeneration, lysosomal storage, dramatic swelling of neuronal soma, perturbations in sphingolipid
catabolism, and sensory physiological deterioration. Our data suggests a genetic interaction with a calcium
exchanger (Calx) pointing to a possible calcium homeostasis deﬁcit in dSap-rmutants. Together these ﬁndings
support the use of dSap-rmutants in advancing our understanding of the cellular pathology implicated in saposin
deﬁciency and related LSDs.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Keywords:
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Saposin deﬁciency is an autosomal recessive lysosomal storage
disorder (LSD) that is typically associated with severe, age-dependent
neurodegeneration and premature death during early childhood. In
humans there are four saposins (saposins A–D), which are encoded by
the prosaposin gene (Furst et al., 1988; Nakano et al., 1989; O'Brien et
al., 1988). The mature, active saposins are produced by cleavage of the
prosaposin precursor during passage through the endosomes to the ly-
sosomes; this function is primarily performed by cathepsin D (Hiraiwagrams; LSD, lysosomal storage
cent protein; RT-PCR, reverse
py; MVB, multivesicular body;
autonomic neuropathy type 1.
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and Genetics, Dresden 01307,
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. This is an open access article underet al., 1997). Once in the acidic lysosome environment, saposins act as
activator proteins and promote the function of hydrolases involved in
sphingolipid degradation (Azuma et al., 1994; Berent and Radin, 1981;
Morimoto et al., 1989; Vogel et al., 1987; Yamada et al., 2004). Muta-
tions in prosaposin therefore cause a primary accumulation of
sphingolipid species in the lysosomes. The location and severity of the
prosaposinmutation dictates the number of saposins that are affected
and hence the degree of sphingolipid accumulation and age of lethality.
Mutations abolishing the prosaposin start codon result in an absence of
prosaposin and therefore all 4 saposins (OMIM #611721); this causes
the most severe pathology and individuals present with severe neuro-
degeneration at birth and die within 4 months (Elleder et al., 1984;
Harzer et al., 1989; Hulkova et al., 2001). Of the single saposin disorders,
saposin A deﬁciency is themost severe and results in death at 8 months
old ((Spiegel et al., 2005); OMIM #611722), whereas the mildest of the
saposin Cmutations cause non-neuronopathic disorders with relatively
mild symptoms until the fourth decade of life ((Tylki-Szymanska et al.,
2007); OMIM#610539). No single saposin D deﬁciencies have been re-
ported in humans.
Because each saposin generally promotes the function of a speciﬁc
sphingolipid hydrolase, the single saposin deﬁciencies resemble
the pathology caused by mutations in their cognate hydrolase (e.g.
(Christomanou et al., 1986); reviewed in (O'Brien and Kishimoto,the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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single saposin deﬁciencies but to a more severe degree (Elleder et al.,
1984; Harzer et al., 1989; Hulkova et al., 2001).
The sphingolipdoses form the largest group of LSDs, yet to date only
one sphingolipidosis, Niemann-Pick Type C (NPC), has been modelled
in Drosophila (Fluegel et al., 2006; Huang et al., 2005; Huang et al.,
2007; Phillips et al., 2008). To broaden our understanding of the
sphingolipidoses, and to help identify pathological events subsequent
to sphingolipid storage, we generated aDrosophilamodel of saposin de-
ﬁciency. TheDrosophila Saposin-related (dSap-r) locus encodes a protein
predicted to contain eight saposin-like domains, each containing the
classic six-cysteine arrangement found in all mammalian saposins.
Characterisation of dSap-rmutants revealed pathology similar to that
of the human disorders, including reduced longevity, progressive neu-
rodegeneration, aberrant sphingolipid levels, and physiological deterio-
ration; all hallmark signs of lysosomal storage. Our analysis reveals a
genetic interaction with the Na+/Ca+ exchanger, CalX, and suggests
a deﬁcit in calcium regulation in the Drosophila model of saposin
deﬁciency.
2. Materials and methods
2.1. Identiﬁcation of Drosophila Sap-r
A blastp search (NCBI; www.ncbi.nlm.nih.gov) was performed to
identify the Drosophila melanogaster prosaposin (PSAP) homologue.
The entire Homo sapiens PSAP protein sequence (CAG33027) was used
to search theD.melanogaster protein database. Standard blastp assump-
tions were applied. A reciprocal search was performed, using the D.
melanogaster d-Sap-rPA sequence to blast the H. sapiens protein data-
base, to ensure the correct homologue was identiﬁed.
2.2. Identiﬁcation of Drosophila Sap-r monosaposins
To identify the putative monosaposins encoded by the dSap-r gene,
each human monosaposin sequence (RCSB Protein Data Bank entries
2DOB, 1N69, 2GTG, 2RB3) was aligned against the full-length dSap-
rPA sequence using the bl2seq tool at NCBI. The H. sapiens and D.
melanogaster monosaposins were aligned using default settings in
ClustalX.
2.2.1. Drosophila stocks
All experimental crosses were grown on maize-meal ﬂy food
at 25 °C. Newly enclosed ﬂies were transferred to standard yeast-
sucrose-agar ﬂy food. The wild type (+/+) control for all experiments
was w1118 crossed to Canton-S. The dSap-rPBac and Df(3R)tll-e (subse-
quently referred to as a ‘deﬁciency’ or Df, a large deletion of the genomic
region encompassing the dSap-r locus) stocks were from the Blooming-
ton stock centre and the dSap-rNP7456 stock was from the Kyoto stock
centre. The dSap-rC27 deletion was generated for this study by
mobilising the P-element from the dSap-rNP7456 parent line. The UAS-
dSap-r transgenic stock was generated for this study as follows. Brieﬂy,
pUAST-dSap-rwas generated by excision of dSap-r cDNA from the pOT2
vector (clone GH08312, BDGP Gold collection), using XhoI and EcoRI
followed by ligation into the pUAST vector. pUAST-dSap-r was
microinjected into w1118 embryos with helper plasmid Δ2–3. UAS-
mCD8GFP and 1407-GAL4 stocks were kindly provided by Andreas
Prokop (University of Manchester, UK).
2.2.2. Longevity
Newly eclosed ﬂies were collected in separate-sex vials of approxi-
mately 10 ﬂies/vial and aged at 29 °C. Flies were transferred to
fresh food every 2–3 days and the number of surviving ﬂies recorded.
Longevity was plotted as the percentage of Day 0 ﬂies alive each subse-
quent day.2.2.3. Immunohistochemistry
For the dSap-r expression pattern, third instar larvae were dissected
and ﬁxed in 3.7% formaldehyde/PBS for 10 min, followed by 3 × 5 min
washes in 0.1% PBST (PBS with 0.1% Triton X-100). Larvaewere labelled
overnight at 4 °Cwithmouse anti-repo-8D12 ormouse anti-elav-9F8A9
diluted in PBST (1:50; Developmental Studies Hybridoma Bank, Univer-
sity of Iowa). Washes were performed as above, followed by incubation
for 2 h at RT in Cy3-conjugated goat anti-mouse IgG (1:200; Jackson
ImmunoResearch). Larvae were washed (as above) and left in 70% glyc-
erol/PBS for 1–2 h before mounting in Vectashield (Vector Laborato-
ries). To label lysosomes, aged adult brains were dissected in 4%
paraformaldehyde/PBS and transferred to fresh ﬁxative for 20 min.
Brainswerewashed 3 × 15–20min in 0.3% PBST followed by incubation
overnight at RT with rabbit anti-Arl-8 (1:500; kindly provided by
Debbie Smith, University of York, U·K) and mouse anti-elav (1:50).
Brains were washed as above, followed by incubation for 3 h at RT in
FITC-conjugated goat anti-rabbit IgG and Cy3-conjugated goat anti-
mouse IgG (1:200; Jackson ImmunoResearch). Brains were washed
and mounted in Vectashield. All images were acquired using a Zeiss
LSM 510 meta Axiovert 200M laser scanning confocal microscope.2.2.4. Fly head processing for light microscopy
Aged ﬂies were brieﬂy dipped in 30% ethanol before being sub-
merged in ﬁxative (4% paraformaldehyde, 1% glutaraldehyde in 0.1 M
sodium phosphate buffer, pH 7.4) and pinned through the abdomen.
The proboscis and accessible air sacs were rapidly removed from the
heads. Heads were transferred to glass vials containing fresh ﬁxative
and were vacuum treated to remove trapped/adherent air. Vacuum-
treated heads were incubated in fresh ﬁxative overnight at 4 °C. All in-
cubationswere performed on a rotatingwheel, unless otherwise stated.
Heads were washed 3 × 10 min in 0.1 M sodium phosphate buffer and
post-ﬁxed in 1% OsO4 for 1 h. Following washes in 0.1 M sodium phos-
phate buffer (3 × 10 min) and dH2O (3 × 10 min), heads were
dehydrated in an acetone series (30%, 50%, 70%, 90%, 3 × 100%; 20 min
each). Heads were incubated in increasing concentrations of Spurr's
resin:acetone (25%, 50%, 75%, 95%, 2 × 100% [at 37 °C]; 45 min each)
followed by incubation in 100% resin overnight at 4 °C without rotation.
Heads were embedded in Spurr's resin (Spurr, 1969) for 24 h at 70 °C.
Three semi-thin serial sections (1.0 μm; Leica Ultracut UCT) were
taken every 10–20 μm until the desired depth was reached. Sections
were dried onto glass slides, stained with 0.6% toluidine blue in 0.3% so-
dium carbonate on a hot plate (80 °C) and rinsed with dH2O. Sections
were imaged using a Zeiss Axiovert 200 microscope equipped with a
Zeiss AxioCam HRm camera.2.2.5. Quantiﬁcation of vacuole number
Vacuoles, transparent clearings in the neuronal tissue, were quanti-
ﬁedmanually under light microscopy for the antennal lobes and the vi-
sual system (eye, lamina, medulla, lobula and lobula plate) from 3 serial
sections per ﬂy head. The sections were matched for depth through the
head. Vacuoleswere counted fromboth sides of the head. ANOVA statis-
tical tests were performed using SPSS software (IBM Corp., USA).2.2.6. Transmission electron microscopy
After reaching the desired depth by semi-thin sectioning, the same
embeddedheads used for lightmicroscopywere sectioned for transmis-
sion electronmicroscopy. Ultrathin sections (60–70 nm)were collected
on 200 and 400 mesh coated grids, treated with uranyl acetate in 50%
ethanol for 10 min and submerged in dH2O to wash. Sections were
stainedwith lead citrate for 10min in the presence of sodiumhydroxide
pellets, followed bywashing in dH2O. Images were captured using anal-
ysis software on a TECNAI G2 (Version 2.18) transmission electron mi-
croscope (120 kV).
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All TEM micrographs were imaged from the cortex surrounding the
antennal lobes (see lower panel in Fig. 3A). Neuronal soma area was
quantiﬁed using ImageJ software. The soma and nuclear boundary of
each neuronwere demarcated and the area calculated by ﬁrst inputting
the number of pixels per micron then using the ImageJ area measure-
ment tool. Neuronal soma area were normalised to nuclear area.
Pseudocolour images were produced using Adobe Illustrator CS4.
Student's t-tests were performed inMicrosoft Excel to determine statis-
tical signiﬁcance.
2.2.8. Lipid extraction and lipidomics analyses
Female adults of the required genotypes were collected on emer-
gence and aged for 5 days. Three brains/biological replicate were dis-
sected in PBS, ﬂash-frozen in 20% methanol using liquid nitrogen, and
stored at−80 °C until lipid extraction was performed. Brain samples
were homogenized and extracted according to the methyl-tert-butyl
ether extraction method (Matyash et al., 2008). All lipid standards
were added to the homogenates prior to extraction (Supplemental
Table 2). After phase separation, the organic phase was used for
lipidomics and the aqueous phase was processed for determining total
protein content using the bicinchoninic acid (BCA) assay (BCA1 kit,
Sigma).
For Mass Spectrometry measurements, the samples were dissolved
in 100 μl methanol containing 0.1% ammonium acetate and subsequent-
ly analyzed using a ﬂow-injection system at a ﬂow rate of 1 μl/min and
5 μl sample injection. Negative and positive ion mode spectra were ac-
quired with a LTQ-Orbitrap XL (Thermo Fisher Scientiﬁc, Germany)
equipped with an Agilent 1200 micro-LC system (Agilent Technologies,
USA) and a Nanomate Triversa utilizing 5 μm ID ESI-chips (Advion, Bio-
sciences, USA).
In the negative mode Phosphatidylinositol (PI), Phosphatidylethanol-
amine (PE), Polyethylene oxide (PE-O), Lysophosphatidylethanolamine
(LPE), Phosphatidylcholine (PC), Ceramide phosphorylethanolamine
(CerPE), Phosphatidylserine (PS), Phosphatidylglycerol (PG) could be
identiﬁed according to their accurate mass (Schwudke et al., 2011). For
PS, the speciﬁc neutral loss of 87 Da was monitored in the linear ion
trap and used for quantiﬁcation. In the positive mode Sph 14:1,
Ceramides and HexCeramides were monitored with MS3 in the linear
ion trap using the long chain base related fragment ions. All MS3 for
quantifying sphingolipids were analyzed using Xcalibur software 2.07
(Thermo Fisher Scientiﬁc, Germany) while all other analyses were per-
formed using LipidXplorer 1.2.4 (Herzog et al., 2011). Absolute levels of
individual lipid species (pmol/μg protein) were summed to arrive at
lipid class abundances. Aminimumof 4 replicateswere used for the anal-
yses. Prism 6 software (Prism Software Corp., USA) was used for graph
representation and for determining signiﬁcant differences applying
ANOVA coupled with post-hoc Bonferroni tests.
2.2.9. RT-PCR
RNAwas extracted from third instar larvaeusing aQIAGENRNeasy kit,
according to manufacturer's instructions. RNA was treated with DNase
prior to cDNA generation. The following primers were used for RT-PCR:
5′TCCTACCAGCTTCAAGATGAC3′ (rp49 Forward), 5′GTGTATTCC
GACCACGTTACA3′ (rp49 Reverse), 5′GCAACTGCAACCTGCTTTCC3′
(dSap-r Forward) and 5′GCATCGTTTCCACCATGTCA3′ (dSap-r Reverse).
All PCR reactions using rp49 and dSap-r primers were performed
with an elongation time of 1 min, an annealing temperature of 50 °C
and 55 °C, and a cycle number of 25 and 35, respectively. dSap-r primers
anneal downstream of the dSap-rC27 deletion, but upstream of the dSap-
rPBac insertion.
2.2.10. Western blotting
Soluble protein was extracted from aged ﬂies using 10 μl lysis buffer
per ﬂy (150 mM NaCl, 20 mM Tris-HCl, pH 8.0, 2 mM EDTA, 0.5% (v/v)
NP-40, 1 completemini protease inhibitor cocktail (Roche)). A standardwestern blotting procedurewas followed including blocking in 5%milk/
TBST (Tris buffered saline supplemented with 0.1% (v/v) Tween-20)
followed by incubation in primary then secondary antibody diluted in
5% milk/TBST. Washes were performed using TBST. The following anti-
bodies were used: rabbit anti-Arl-8 (1:2000; kindly provided by Debbie
Smith, University of York, UK), mouse anti-β-tubulin E7 (1:100; Devel-
opmental Studies Hybdridoma Bank, University of Iowa, USA), mouse
anti-cathepsin-L (1:250; R&D Systems), hoseradish peroxidase (HRP)-
conjugated goat anti-rabbit (1:6000; Sigma) and HRP-conjugated goat
anti-mouse (1:10,000; Sigma). Bandswere visualised using ECL reagent
(GE Healthcare, UK) and developed using a Xograph machine. Densi-
tometry was performed using ImageJ. Band intensities were ﬁrst nor-
malised to the tubulin control and then to the 5d old wild type control.
2.2.11. Behavioural analyses
The climbing ability of female ﬂies was assessed by tapping cohorts
of 5 ﬂies to the bottom of a 100 ml glass measuring cylinder and video
recording the climbing response over 45 s. The data were analyzed by
quantifying the climbing speed of eachﬂy over 10% intervals of themea-
suring cylinder. The maximum speed for each ﬂy was used to calculate
the average speed per genotype. The same ﬂies tested at 5-days old
were re-tested at 22-days old, when possible. ANOVA statistical tests
were performed using SPSS software (IBM Corp., USA).
2.2.12. Electroretinograms
ERGs were performed as described in (Hindle et al., 2013). Brieﬂy,
aged female ﬂies were left to climb a trimmed 200 μl pipette tip and
were blown to the end leaving the ﬂy head protruding. The ﬂy was
ﬁxed into position with nail varnish. Glass electrodes were pulled and
ﬁlled with Drosophila Ringer solution (0.13 M NaCl, 4.7 mM KCl,
1.9 mM CaCl2) (34). A recording electrode was placed against one eye
and a reference (earth) electrode placed against the proboscis usingmi-
cromanipulators. The ﬂies were dark-adapted for 5 min (Fig. 6B - C) or
2 min (Fig. 6D–E). ERGs were recorded in response to 5 × 750 ms blue
light pulses with 10 s intervals. Light pulses were provided by a blue
LED lamp (Kingbright, Taiwan) controlled by DASYLab software (Mea-
surement Computing Corp., USA). ERGs were analyzed using DASYView
software (customised software, C. Elliott freely available download,
http://biolpc22.york.ac.uk/dasyview).
3. Supplemental methods
3.1. Epiﬂuorescence
Organs were dissected from adult ﬂies in PBS and, in some cases,
stained with DAPI. Organs were imaged using a Zeiss stereomicroscope
equipped with an Axiocam MRc5 camera, a Neolumar S 1.5× FWD
30 mm lens and a HBO 100 mercury lamp.
4. Results
4.1. dSap-r has homologous sequence structure and similar expression pat-
tern to mammalian prosaposin
The Drosophila prosaposin (PSAP) homologue (Saposin-related;
dSap-r) was identiﬁed by a BLAST screen using the complete human
PSAP protein sequence (blast E value 4e−36). The dSap-r locus is locat-
ed at band 100A7 of the right arm of the third chromosome. There are
two predicted transcripts for dSap-r (dSap-r RA and dSap-r RB); dSap-r
RB appears to be an in-frame truncation of dSap-r RA (Fig. 1A).
A bl2seq alignment of each humanmonosaposin (Sap A–D)with the
dSap-r protein revealed eight homologous Drosophila saposins (dSaps
1–8). Each dSap contained the six conserved cysteine residues critical
for saposin function (Fig. 1B). Five of the dSaps also contained a poten-
tial glycosylation signal between the second and third cysteines,
Fig. 1. Drosophila Sap-r is expressed in glia. A. The Drosophila prosaposin homologue Saposin-related (dSap-r) consists of seven exons and is present on the right arm of the third
chromosome (3R) at position 100A7. The dSap-r gene contains two potential transcript start sites (ATG), which result in the production of a transcript consisting of the entire coding
sequence (dSap-rRA, 3451 bp) and an in-frame, truncated version (dSap-rRB, 3349 bp) (black lines). The dSap-rC27 mutant allele was generated by P-element mobilisation from the
P{GawB}NP7456 line and is a 2.5 kb deletion. The dSap-rPBac mutant allele consists of a 5.971 bp piggyBac transposon insertion into the largest dSap-r exon. The deletion in the
deﬁciency line Df(3R)tll-e spans cytogenetic bands 100A2–100C5, which includes the dSap-r gene. B. A Clustal X alignment of the 8 predicted Drosophila melanogaster saposins (dSaps)
and the 4 Homo sapiens saposins (hSaps). Asterisks, conserved cysteine residues; underlining, glycosylation sites in each hSap and possible homologous sites in the dSaps. Blue
highlights identical residues; yellow highlights similar residues (80% threshold setting). C. Confocal images of third instar larvae brains expressing mCD8eGFP or eIF4AIIIGFP (n N 5)
under the control of dSap-rNP7456 GAL4 and stained with α-repo (glial nuclear marker) or α-elav (pan neuronal marker). Scale bars: 20 μm.
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ing and function (Hiraiwa et al., 1993b).
Saposin proteins are expressed in the mammalian nervous system
and their loss usually causes severe neurodegeneration (Sun et al.,
1994; VanDen Berghe et al., 2004; Yoneshige et al., 2009).We therefore
investigated the expression pattern of dSap-r in the nervous system.
The dSap-rNP7456 GAL4 enhancer-trap insertion was used to drive a
membrane localised GFP reporter (mCD8GFP) in a dSap-r-speciﬁc ex-
pression pattern. Third instar larvaewere dissected and stainedwith ei-
ther a glial or neuronal antibody (α-repo or α-elav, respectively). The
membrane GFP reporter localised around repo-positive nuclei, suggest-
ing that dSap-r is expressed in glial cells (Fig. 1C). The GFP reporter was
also shown to faintly surround elav-positive neuronal nuclei, however
this is likely to represent expression in glial cells that surround the neu-
ronal cell bodies. To conﬁrm whether dSap-r is expressed in neurons, a
nuclear GFP reporter (eIF4AIII:GFP) was driven by the dSap-rNP7456 ele-
ment. No colocalisation was found between the nuclear GFP reporter
and neuronal nuclei, suggesting that neurons have no or very little
dSap-r expression (Fig. 1C). The nuclear GFP colocalised with the glial
nuclear marker, further conﬁrming dSap-r expression in glia.
In mammalian visceral organs, prosaposin is expressed ubiquitously
at low levels; however moderate to high expression levels are found in
the jejunum and tubular epithelial cells in the kidney cortex, epithelial
cells of the oesophagus, pancreatic duct and bile duct, and the hepato-
cytes of the liver (Sun et al., 1994). PSAP has also been shown to pro-
mote spermiogenesis and fertility (Amann et al., 1999; Hammerstedt,
1997). Using the mCD8GFP reporter in conjunction with the dSap-
rNP7456 enhancer-trap element, dSap-r was shown to be highly
expressed in the reproductive system, the digestive system,Malpighian
tubules (Drosophila kidney), and the fat bodies (Drosophila liver and ad-
ipose tissue) of the adult ﬂy (Fig. S1).
The similar expression pattern of dSap-r andmammalian saposins in
cells of the nervous, reproductive, digestive, and renal systems, and theliver is suggestive of conserved functions, and therefore supports the
use of Drosophila to model these disorders.
4.2. dSap-r mutation causes a reduced longevity
Patients with saposin deﬁciency die prematurely, usually within the
ﬁrst decade of life. To testwhether dSap-rmutants also die prematurely,
we ﬁrst generated deletions of the dSap-r locus via an imprecise P-ele-
ment mobilisation strategy. The dSap-rC27 allele is a deletion of the
ﬁrst two exons of the dSap-r locus (Fig. 1A).We also identiﬁed a PiggBac
transposon insertion, dSap-rPBac, in the 4th exon of the dSap-r locus
(Fig. 1A). To assess the dSap-r transcript levels in the dSap-r mutants,
RT-PCR was performed (Fig. 1A and 2C). The dSap-r transcript was al-
most undetectable in dSap-rC27/Df mutants and is likely to reﬂect
dSap-rRB levels, as the dSap-rRA start site is deleted in this mutant. In
contrast, dSap-r transcript levels in the dSap-rPBacmutant were indistin-
guishable from wild type; however, the dSap-r primers were designed
to anneal upstream of the dSap-rPBac insertion. Production of saposins
from the dSap-r locus prior to the PBac transposon insertion is therefore
possible.
Next we tested the effect of these mutant dSap-r alleles using, lon-
gevity assays. Each of the three dSap-r mutant allelic combinations
caused a reduction in longevity compared to wild type ﬂies (Fig. 2A).
Median survival for wild type ﬂies was approximately 35 days, whereas
50% of dSap-r mutants survived only 6 days (dSap-rC27/Df), 15 days
(dSap-rC27/PBac) or 18 days (dSap-rPBac/Df). This suggests that the dSap-
rC27 mutant allele is more severe than the dSap-rPBac mutant allele.
Taken together with the RT-PCR results, this suggests that the dSap-
rC27 mutant allele is likely a strong loss-of-function mutation, whereas
the dSap-rPBac mutant allele may produce dSap-r protein with reduced
or aberrant function.
To conﬁrm that the dSap-r mutations were responsible for the re-
duced longevity, ﬂies carrying a UAS-dSap-r transgene were generated
Fig. 2. Reduced longevity in dSap-r mutants. A & B. Longevity of ﬂies with different dSap-rmutant allelic combinations was assessed at 29 °C. Rescue of dSap-rmutant longevity was
performed by expressing dSap-r cDNA in the neurons (A) or glia (B) of dSap-r mutants using the 1407- and repo-GAL4 drivers. Neuronal or glial expression of dSap-r in a wild type
background was performed as a transgene control. Longevity was plotted as the percentage of Day 0 ﬂies surviving for each genotype. n N 60 ﬂies for each genotype. C. cDNA from
wild type (+/+), dSap-rPBac/Df (PBac/Df) mutant and dSap-rC27/Df (C27/Df) mutant third instar larvae were ampliﬁed using rp49 control and dSap-r primers.
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pression of dSap-r using either Act5c-GAL4 or tubulin-GAL4 resulted in
lethality prior to third instar; we therefore used dSap-r expression driv-
en by the neuronal 1407-GAL4 (Fig. 2A) or the glial repo-GAL4 (Fig. 2B)
for rescue experiments. Expression of dSap-r in neurons of all dSap-r
mutant combinations resulted in a substantial rescue of longevity and
in most cases longevity was equivalent to the transgene control. Glial
dSap-r expression was only driven in the dSap-rC27/PBac mutants, due
to greater genetic ease of repo-GAL4 recombination using the dSap-
rPBacmutant allele. Glial dSap-r expression provided a substantial rescue
of dSap-rC27/PBac mutant longevity, however, not to the same degree as
the neuronal 1407-GAL4 expression. These results conﬁrm that the re-
duced longevity in dSap-rmutants was due to dSap-rmutations.
4.3. Age-dependent neurodegeneration in dSap-r mutants
The Saposin-deﬁciencies are primarily classed as progressive neuro-
degenerative disorders. Therefore, we next assessedwhether our dSap-r
model showed age-dependent neurodegeneration. In Drosophila,
vacuolisation of the brain, the appearance of clearances within the neu-
ral tissue is a hallmark of neurodegeneration (Dermaut et al., 2005;
Phillips et al., 2008), which can be quantiﬁed from 1 μm tissue sections
at the lightmicroscopy level. Horizontal sectionswere taken from5-day
and 22-day-old ﬂy heads and stained with toluidine blue. Vacuolisation
was speciﬁcally observed in regions of sensory function, mainly the an-
tennal lobes, the eye, and optic lobes (Fig. 3A). Vacuole number was
quantiﬁed for these sensory regions (Fig. 3B & C) where we observed
that vacuole number in most 5-day-old dSap-r mutants was not
signiﬁcantly different from controls, with the exception of limited
vacuolisation observed in the antennal lobes of the dSap-rC27/Df mu-
tants. As the ﬂies aged, the number of vacuoles increased in all dSap-r
mutants, indicative of progressive neurodegeneration. In the visual
system, vacuole number increased by 4–18 fold in the dSap-rmutants
compared to less than a 1.5 fold increase in the controls. In the
olfactory system (antennal lobes), the controls showed a modest 1.5–
3-fold increase in vacuole number. In contrast, the dSap-rPBac/Df and
dSap-rC27/PBac mutants showed a massive 6-fold and 16-fold increase
in vacuole number, respectively. Although the dSap-rC27/Df mutants
showed the greatest number of vacuoles at 22-days old, the increasewas only 3-fold due to the increased severity of vacuolisation at 5-
days old.
4.4. dSap-r mutants have age-dependent lysosomal storage defects
LSDs are characterised by lysosomal dysfunction leading to the stor-
age of undegraded material in the lysosomes (Jardim et al., 2010).
Therefore, to assess the degree of lysosomal dysfunction and storage
in dSap-r mutants, western blotting was performed using antibodies
for two lysosomal proteins: Arl-8 and cathepsin-L.
Arl-8 is an Arf-like GTPase that localises to the lysosomes (Hofmann
and Munro, 2006). Cathepsin-L is a lysosomal enzyme that is synthe-
sised as an inactive precursor and cleaved in the lysosome to form its
mature, active form (Erickson, 1989). In 5-day-old ﬂies, Arl-8 levels
were similar between wild type and dSap-r mutants. However, in 22-
day-old dSap-r mutant ﬂies, Arl-8 levels were increased compared to
wild type and the 5-day-old samples (Fig. 4A). Similarly, an increase
in the mature form of cathepsin-L was found in all 22d old dSap-rmu-
tants. This age-dependent increase in Arl-8 and mature cathepsin-L
storage is show by densitometry quantiﬁcation, however these data
did not reach signiﬁcance due to a variability in the degree of storage
in the dSap-rmutants. These data suggest a trend of age-dependent dys-
function and accumulation of lysosomes and/or lysosomal enlarge-
ment/swelling in dSap-rmutants, which is consistent with the human
disease.
In addition to western blotting, the Arl-8 antibody was used for im-
munohistochemistry onwild type and dSap-rC27/Dfmutant adult brains.
An overall increase in ﬂuorescencewas observed in the aged dSap-rmu-
tant brains, particularly in central brain regions and the antennal lobes
(Fig. 4B). Together with our light microscopy analysis of brain sections,
this reveals that regions of severe neurodegeneration coincide with the
regions of the CNS showing the most lysosomal storage.
4.5. dSap-rC27/Df mutant CNS soma are enlarged with storage
To investigate this lysosomal storage defect further, we performed
transmission electron microscopy on 22-day old dSap-rC27/Df mutant
antennal lobes, the same region where we saw the increased severity
of neurodegeneration. We observed that dSap-rC27/Df mutant neuronal
Fig. 3. Progressive neurodegeneration in sensory regions of dSap-rmutants. A. Representative images of 1 μmsections through 5-day-old and 22-day-old control (dSap-rC27/+) and dSap-r
mutant (dSap-rC27/Df and dSap-rC27/PBac) heads are shown at 20× magniﬁcation (top 2 rows) and 63× magniﬁcation (bottom 2 rows, eye (upper row) and antennal lobe (lower row)).
Scale bars: 100 μm. B & C. Quantiﬁcation of vacuole number was performed on 3 serial sections per ﬂy (n ≥ 3 ﬂies). Vacuoles were counted for the visual (B; eye, lamina, medulla and
lobula complex) and olfactory (C; antennal lobes) systems at both sides of the brain. Quantiﬁcation is shown for all controls and dSap-rmutants tested. Genotypes tested: +/+ (wild
type); Df/+, PBac/+ and C27/+ (dSap-r heterozygotes); PBac/Df, C27/Df and C27/PBac (dSap-rmutants). Error bars: ±sem. ***p ≤ 0.001.
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age material. To quantify this difference in soma size, the boundaries of
each neuron were marked using ImageJ and the soma area measured
(Fig. 5A). Measuring the average soma area revealed an almost 2.5-
fold increase in dSap-rC27/Df mutants compared to wild type (Fig. 5B).
When normalised to nucleus area, the dSap-rC27/Df mutant soma were
almost 2-fold larger, suggesting that nuclear area is also increased in
dSap-rC27/Df mutant neurons (Fig. 5C). We also observed cell enlarge-
ment and increased storage in glial cells of the dSap-rC27/Df mutant
adult CNS (Supplemental Fig. 2).
As a common characteristic of LSDs is the accumulation of membra-
nous storage material known as multilamellar bodies (MLBs) andenlarged multivesicular bodies (MVBs), we investigated whether the
22-day old dSap-rC27/Df mutants showed these hallmark signs in the
cortex surrounding the antennal lobes. Electron micrographs revealed
neurons with an abundance of electron dense storage material that
had a complex morphology; some regions were populated by elec-
tron-lucent droplets, some contained variable numbers of MLBs, and
others were densely packed with MVBs (Fig. 5D). Electron micrographs
also revealed an abundance of storedmaterial in photoreceptor neurons
of the ﬂy retina (Fig. 5E), another sensory region of the nervous system
that showed severe degeneration (Fig. 3A). This stored material had
a similar morphology to that found in the antennal lobe neurons
(Fig. 5D). High magniﬁcation images showed a variable phenotype in
Fig. 4. Progressive lysosomal storage in dSap-rmutants. A. Western blots showing the abundance of the lysosomal proteins Arl-8 and cathepsin-L in 5-day-old and 22-day-old wild type
(+/+), dSap-rC27/Df (C27/Df), dSap-rC27/PBac (C27/PBac) and dSap-rPBac/Df (PBac/Df)mutants (n=2). Tubulin abundance is shown as a loading control. Average band intensities and S.E.M
are shown below. B. Confocal micrographs of 22-day-old wild type (+/+) and dSap-rC27/Df mutant brains showing Arl-8 localisation and abundance (n N 8). Elav staining shows the
similar orientation of both wild type and dSap-rC27/Df mutant brains. Scale bar: 100 μm.
83S.J. Hindle et al. / Neurobiology of Disease 98 (2017) 77–87the rhabdomeres, the light responsive component of the eye. Most
rhabdomeres showedmassive accumulation of electron-densematerial
yet some were found to be structurally intact (Fig. 5E).
The ultrastructural nature of storage material in saposin deﬁciency
patients and mammalian models has been shown to be highly variable,
with the presence ofMLBs,MVBs and electron-lucent droplets (Fujita et
al., 1996; Harzer et al., 1989; Hulkova et al., 2001; Oya et al., 1998). The
ultrastructural pathology observed in the dSap-r mutants is therefore
consistentwith the reported disease phenotype, which further supports
the use of this model for investigating saposin deﬁciency.
4.6. Sphingolipids accumulate in dSap-r mutant brains
To gain a greater insight into the nature of the stored material in
dSap-rmutants, we performed mass spectrometry. As saposin deﬁcien-
cy leads to the accumulation of a complex array of sphingolipids and
sphingolipid intermediates, we determined the nature of sphingolipid
perturbation in dSap-r mutants by monitoring Hexosyl-Ceramides
(HexCer), Ceramide phosphorylethanolamine (CerPE), Ceramide (Cer)
and Sphingosine (the breakdown product of Ceramide;(Yuan et al.,
2011)) in conjunction with a lipidomic analysis of all major membrane
phospholipids in the brain.
Brains from 5-day old ﬂies revealed a consistent increase in
sphingolipids, particularly sphingosine, in all dSap-rmutants examined
(Fig. 5F). Notably, comparison of the sphingosine:ceramide ratios in
controls and mutants revealed a striking imbalance between these
sphingolipid intermediates in the dSap-rC27/Df mutants (Fig. 5G). We
did not observe a signiﬁcant change in HexCer across the mutant
combinations.
Changes in particular phospholipid classeswere observed. However,
unlike the sphingolipids, there is no speciﬁc and consistent trend for
changes in phospholipid classes across the different dSap-rmutant com-
binations tested (Fig. 5H&I).
4.7. dSap-r mutants show progressive physiological decline
After establishing that dSap-rmutants showed age-dependent neu-
rodegeneration, we investigated the effect of dSap-r mutation on the
physiology of the whole ﬂy. We observed that the dSap-rmutant ﬂies
showed an age-dependent decline in locomotion; the 20+ day-old
dSap-rmutants rarely climbed the vial during spontaneous activity. To
quantify this loss of climbing behaviour, 5-day and 22-day-old female
ﬂies were tapped to the bottom of a measuring cylinder and their
climbing response was captured by video for 45 s. Calculation of
climbing speed revealed that the 22-day-old dSap-rC27/Df mutants
were only able to climb at 5% of their 5-day-old speed compared tomaintenance of 36% of 5-day climbing speed for the dSap- rC27/+ con-
trols. The dSap-rC27/PBac mutants showed an intermediate phenotype
maintaining 16% of their 5-day climbing ability at 22-days old. These
data conﬁrm an age-dependent deterioration of climbing behaviour in
the dSap-rmutants (Fig. 6A).
The decline of locomotor ability in dSap-rmutants could be due to a
deterioration ofmotor neuron or sensory neuron function; however,we
have shown that sensory regions of the brain, including the visual sys-
tem, are particularly vulnerable to dSap-r mutation. To determine
whether the photoreceptor neurons and their underlying optic lobe
synapses were functionally intact, we measured the ability of the ﬂy
eye to respond to light using the electroretinogram (ERG). The ERG is
a classic method for investigating photoreceptor and lamina neuron
function by measuring the summed potential difference on the surface
of the ﬂy eye in response to light pulses (Coombe, 1986; Heisenberg,
1971). Different components of the ERG trace represent the net inﬂu-
ence of different parts of the visual system, therefore, the integrity of
the different components of visual transduction can be assessed using
this simple approach.
ERG recordings in 5-day-old dSap-rC27/Df mutants were not signiﬁ-
cantly different from controls in all components measured (Fig. 6B &
C). However, 22-day-old dSap-rC27/Df mutants showed a severe deteri-
oration of all components of the ERG compared to controls. The dSap-
rC27/Df mutant ERG potential deteriorated to 46% of its 5-day value,
whereas the dSap-rC27/+ control ERG potential only decreased to 77%
of its 5-day value. This severe deterioration of the ERG amplitude in
dSap-rC27/Dfmutants was also matched by a 5-fold increase in recovery
time after termination of the light pulse. This suggests that neuronal
function in both the retina and underlying optic lobe is severely com-
promised in dSap-rmutants.
4.8. Calcium homeostasis is defective in dSap-r mutants
Calcium homeostasis defects have been highlighted as one aspect of
cellular pathology implicated in the sphinoglipidoses (Ginzburg et al.,
2004; Jeyakumar et al., 2005; Lloyd-Evans et al., 2008). For example,
in NPC1 cells lysosomal calcium levels have been shown to be abnor-
mally low, and by increasing cytosolic calcium levels NPC pathology in
both NPC1 cells and mouse models can be substantially rescued
(Lloyd-Evans et al., 2008). Calcium homeostasis defects have also
been implicated in other sphingolipidoses (Gaucher's, Sandhoff
and GM1-gangliosidosis); however, in these disorders an increase,
rather than a decrease, in cytosolic calcium levels was found to be
pathological (Lloyd-Evans et al., 2003a; Lloyd-Evans et al., 2003b;
Pelled et al., 2003; Pelled et al., 2005). This suggests that both abnormal-
ly low or abnormally high levels of calcium might be implicated in
Fig. 5.Neuronal swelling, degeneration and lipid storage are abundant indSap-rmutant brains A. Transmission electronmicrographs showing neuronal cell bodies adjacent to the antennal
lobes of 22-day-old wild type (+/+) and dSap-rC27/Df mutants (n= 3). Each soma has been demarcated in grey and rendered a different pseudocolour. The nuclei are demarcated by
dashed lines. T, trachea; V, vacuole; white asterisk, fat body. Scale bar: 2 μm. B & C. Quantiﬁcation of 22-day-old wild type (+/+) and dSap-rC27/Df (C27/Df) mutant soma area (B) and
cell:nucleus ratio (C). **p b 0.005. D. Transmission electron micrographs of 22-day-old wild type (+/+) and dSap-rC27/Df mutant neuronal cell bodies surrounding the antennal lobes
(n = 3). Multivesicular bodies and multilamellar bodies (arrows) are abundant in dSap-rC27/Df mutant neuronal cell bodies. Scale bars: 2 μm (i–v), 100 nm (vi). E. Transmission
electron micrographs showing the integrity of the ommatidia in 22-day-old wild type (+/+) and dSap-rC27/Df mutants. Arrowheads mark vacuoles and arrows mark electron lucent
material within regions of electron-dense storage. Scale bars: 5 μm (i & iv), 2 μm (ii & v) and 500 nm (iii & vi). F\\I. Quantiﬁcation of sphingosine levels (F), the sphingosine:ceramide
ratio (G), the phosphatidylinositol level (H), and phosphatidylserine (I) in 5-day-old controls and dSap-rmutant brains. Genotypes tested: +/+ (wild type); Df/+, PBac/+ and C27/+
(dSap-r heterozygotes); PBac/Df, C27/Df and C27/PBac (dSap-rmutants). *p b 0.05, **p b 0.01, ***p b 0.000, ****p b 0.0001 as determined by ANOVA followed by post-hoc Bonferonni test.
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mechanistically linked to an imbalance in sphingolipid levels in a ﬂy
model of retinal degeneration (Yonamine et al., 2011). Based on our
ﬁndings of an imbalance of sphingolipids prior to severe signs of neuro-
degeneration in the dSap-r mutants, we hypothesised that calcium
levels may also be altered.
To investigate calcium misregulation and its impact on dSap-r neu-
rodegeneration, we used a similar approach to Yonamine et al. (2011)
and manipulated calcium levels in the ﬂy eye. We overexpressed the
plasma membrane calcium exchanger (CalX) in the ﬂy eye using the
NINAE (Rhodopsin 1) promoter andmeasured its effect on retinal func-
tion using ERGs. CalX transports calcium ions out of the neuron in ex-
change for sodium ions (Wang et al., 2005). Therefore, if dSap-rmutants have a reduced cytosolic calcium level, CalX expression should
exacerbate the degeneration and function of the photoreceptors. In con-
trast, the ERG should be substantially rescued if dSap-rmutation causes
an increased cytosolic calcium level.
Overexpression of CalX in an otherwise wild type ﬂy resulted in a
modest degeneration of the ERG to 81% of its 5-day level (Fig. 6D & E).
When CalX was expressed in a dSap-rC27/Df mutant background, there
was no effect on the 5-day-old dSap-rC27/Df mutant ERG. However, as
the ﬂies aged, CalX expression induced a decrease in dSap-rC27/Df mu-
tant vision to only 9% of its 5-day-old level; this is in contrast to the de-
terioration of the dSap-rC27/Df mutant ERG to 64% of its 5-day-old level,
and therefore suggests that the dSap-r mutation may cause an abnor-
mally reduced cytosolic calcium level.
Fig. 6. Calcium homeostasis defects are associated with progressive deterioration of visual function in dSap-rmutants. A. 5-day-old (white bars) and 22-day-old ﬂies (grey bars) were
subjected to climbing assays (n N 20 ﬂies). The climbing speed of dSap-rC27 heterozygotes (C27/+), dSap-rC27/Df (C27/Df) and dSap-rC27/PBac (C27/PBac) mutants are shown. Error bars:
±sem. **p b 0.005 and ***p ≤ 0.001. B. Quantiﬁcation of electroretinogram (ERG) amplitude and recovery rate after a blue light pulse. The recovery rate is the time taken for the
potential to reach half way between the off-transient and base-line potentials after termination of the light pulse. C. Representative ERG traces for 5-day-old and 22-day-old control
(dSap-rC27/+) and dSap-rC27/Df mutant females following a blue light pulse. D. Quantiﬁcation of ERG amplitude after a blue light pulse in 5-day-old and 22-day-old wild type
overexpressing the calcium exchanger CalX in the eye (CalX/+), dSap-rC27/Df mutants (C27/Df) and dSap-rC27/Df mutants overexpressing CalX in the eye (CalX/+;C27/Df). E.
Representative ERG traces for 5-day-old and 22-day-old wild type overexpressing CalX (CalX/+), dSap-rC27/Df mutants and dSap-rC27/Df mutants expressing CalX (CalX; dSap-rC27/Df).
N ≥ 7 ﬂies per condition. *** p ≤ 0.001.
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To further our understanding of the pathology related to saposin de-
ﬁciency, we generated a Drosophilamodel. The Drosophila prosaposin
homologue dSap-r was revealed to contain eight saposin-like domains,
which all contained the six-cysteine primary sequence common to all
saposins (this investigation, (Hazkani-Covo et al., 2002)). We showed
that most of the dSap peptides contain a predicted glycosylation site, a
feature critical for saposin folding and function (Hiraiwa et al., 1993b).
The sequence similarities between the mammalian and Drosophila
saposins suggested that we had identiﬁed the correct ortholog.
To further characterise dSap-r, we investigated its expression pat-
tern using GFP reporters. Both membrane and nuclear GFP reporters
conﬁrmed the expression of dSap-r in glia, as reported by (Freeman et
al., 2003). Although mammalian saposins are expressed in neurons,
our ﬁndings suggested that dSap-r is either not expressed in neurons
or is expressed at a level below the threshold of our reporter.
Transcriptomic data from FACS isolated neurons, glia and surface glia
(blood-brain barrier) (DeSalvo et al., 2014) shows that dSap-r is
expressed in neurons, glia and surface glia, and may therefore be more
ubiquitous than the dSap-rNP7456 GAL4 enhancer-trap is reporting.
In addition, mammalian prosaposin is abundant in secretory ﬂuids,
including cerebrospinal ﬂuid, seminal ﬂuid, milk, bile and pancreatic
ﬂuid (Hineno et al., 1991; Hiraiwa et al., 1993a; Kondoh et al., 1991;
Patton et al., 1997); in fact prosaposin is one of themain secretory prod-
ucts of Sertoli cells in the male reproductive system (Sylvester et al.,
1989). Therefore, it is quite possible that Drosophila glia provide dSap-
r to neurons by glial secretion and neuronal uptake. This notion is con-
sistent with our ﬁndings that dSap-rmutant longevity can be substan-
tially rescued by expressing dSap-r directly in neurons, which suggests
a neuronal requirement for dSap-r. This potential non-autonomous
function of dSap-r has important implications for future therapeutic
strategies as it suggests that a source of prosaposin secreting cells
could provide a successful intervention for these conditions.This investigation also revealed high dSap-r expression in the
male and female reproductive organs, the digestive system, Drosophila
renal system (Malpighian tubules), and the Drosophila liver equivalent
(the fat bodies). Mammalian prosaposin has a role in spermiogenesis
and improving fertility (Amann et al., 1999; Hammerstedt, 1997;
Morales et al., 2000; Sun et al., 2007), and is also relatively abundant
in subsets of cells of the small intestine, kidney and liver (Sun et al.,
1994). Therefore, in addition to having a conserved primary sequence,
dSap-r also has a conserved tissue expression suggesting a conserved
function.
After conﬁrming the identity of the Drosophila prosaposin
orthologue and its expression pattern, we generated a dSap-r loss-of-
function model and assessed its pathology. Ultrastructural analysis re-
vealed extensive storage in the dSap-rmutant nervous system (MLBs,
enlarged MVBs and lipid droplets), characteristic of LSD pathology.
Lysosomal storage was also conﬁrmed by western blotting, which
showed progressive accumulation of two lysosomal markers (Arl8 and
cathepsin-L) in the dSap-r mutants, and mass spectrometry revealed
early accumulation and imbalance of sphingolipid intermediates in
dSap-rmutants.
The dSap-rC27/Df mutants were the most severe mutants in all
assays tested. They also showed the most severe imbalance of
sphingosine:ceramide, whilst having similar levels of sphingosine and
lower levels of ceramide than the other mutant allelic combinations.
This therefore supports previous ﬁndings that the ratio of sphingolipids
ismore important than the total levels of individual sphingolipidswhen
considering the effect on pathology (Fewou et al., 2005; Levade et al.,
1995; Matsuda et al., 2004; Sun et al., 2008; Sun et al., 2007).
In prosaposin and individual saposin deﬁciency mouse models, the
stored material was described as very heterogeneous with electron-
dense and electron-lucent inclusions, MLBs and MVBs (Matsuda et al.,
2004; Matsuda et al., 2001; Oya et al., 1998; Sun et al., 2010a; Sun et
al., 2010b; Sun et al., 2008; Sun et al., 2007). This phenotype is strikingly
similar to the ultrastructural pathology of dSap-rmutants.
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with 50% death within 18 days; this equates to a 41–49% reduction in
longevity, which is comparable to most Drosophila LSD models (40–
55% reduction) (Hickey et al., 2006; Huang et al., 2007; Min and
Benzer, 1997; Nakano et al., 2001; Phillips et al., 2008). The dSap-rmu-
tants also showed an age-dependent deterioration of spontaneous and
evoked locomotion, which correlated with the progressive nature of
vacuolarisation in the sensory regions of the dSap-rmutant nervous sys-
tem. Thismay suggest that locomotion deterioration is primarily a result
of failed perception of sensory cues rather thanmotor neuron ormuscle
degeneration. This notion is supported by a less severe deterioration in
dSap-rmutant jump performance using an assay that bypasses sensory
neuron input (data not shown). A similar degeneration in sensory func-
tion is observed in both Drosophila and mouse models of NPC1
(Claudepierre et al., 2010; Palladino et al., 2015; Phillips et al., 2008;
Yan et al., 2014), and recently recognised in NPC1 patients (Zafeiriou
et al., 2003). These results suggest a particular sensitivity of sensory
neurons to disruptions in sphingolipidmetabolism. This is also support-
ed by the severe sensory degeneration observed in the sphingolipid
synthesis disorder Hereditary Sensory and Autonomic Neuropathy
Type 1 (HSAN1) (Dawkins et al., 2001). HSAN1 is caused by mutations
in the ﬁrst enzyme of the sphingolipid synthesis pathway: serine-
palmitoyl transferase (SPT). AlthoughHSAN1 is a sphingolipid synthesis
disorder and saposin deﬁciency is a disorder of sphingolipid degrada-
tion, the sensory degeneration in both of these disorders reﬂects a com-
mon cellular pathology: a defect in sphingolipid homeostasis. Therefore,
sensory degeneration may result from an absence of sphingolipids, an
abnormal accumulation of sphingolipids, an imbalance of sphingolipids,
or a combination of all three.
Although retinal degeneration and storage has been reported in
other Drosophilamodels of LSDs (Dermaut et al., 2005; Myllykangas et
al., 2005; Phillips et al., 2008; Tuxworth et al., 2009), the pathological
mechanism remains unclear. In several mammalian sphingolipidoses
models, recent reports have revealed calcium homeostasis defects.
Therefore, a calcium exchanger was overexpressed in the ﬂy eye of
dSap-rmutants to determine whether altering cytosolic calcium levels
had any effect on dSap-rmutant retinal function. Aging of dSap-rC27/Df
mutants caused a 36% reduction in retinal function; a similar but less se-
vere (19%, n.s.) deterioration was also seen after expression of CalX in
aged wild type ﬂies. Overexpression of CalX in a dSap-r mutant back-
ground caused a severe (92%) deterioration of retinal function, leaving
the 22-day-old ﬂies almost completely unresponsive to light. This sig-
niﬁcant genetic interaction suggests that calcium regulation may be
compromised in dSap-rmutant photoreceptors, leading to neurodegen-
eration and perturbed sensory function. Further work is required to de-
termine the severity of the calcium homeostasis defect in dSap-r
mutants, including its temporal and spatial (neurons vs glia)
involvement.
The Drosophila NPC1model revealed degeneration of the visual sys-
temand concomitant deterioration of the ERG that resembles that of the
dSap-r mutant model (Phillips et al., 2008). Although classically
characterised as a cholesterol-storage disorder, mammalian NPC pa-
thology has more recently been linked to sphingolipid storage (Lloyd-
Evans et al., 2008), speciﬁcally sphingosine storage leading to a deﬁcit
in lysosomal calcium regulation (Lloyd-Evans et al., 2008). In support
of this, in cell culture, NPC1 cells contained approximately 65% less lyso-
somal calcium compared to control cells. It was shown that the
sphingolipid intermediate sphingosine was responsible for this calcium
homeostasis defect (Lloyd-Evans et al., 2008), directly linking calcium
homeostasis defects to the accumulation of sphingolipids in the
sphingolipidoses.
Our sphingolipid analyses showed that sphingosine levels were sig-
niﬁcantly increased in all dSap-rmutant brains. Like in NPC1 cells, this
may cause a decrease in lysosomal calcium in dSap-r mutants, which
was further exacerbated by overexpression of CalX. Further evidence
of a link between sphingolipid metabolism and calcium homeostasiswas also provided by Yonamine et al. (2011), who revealed that retinal
degeneration caused by imbalances in sphingolipid metabolites was
suppressed by mutations in the Drosophila CalX. Similar to Yonamine
et al. (2011) we have also shown an imbalance in the ratio between
two sphingolipid intermediates in dSap-rmutant brains, providing fur-
ther support of calciumhomeostasis defects being a likely cause of dSap-
rmutant pathology.
In conclusion, we suggest that early accumulation of sphingosine, or
the imbalance of the sphingosine:ceramide ratio, may lead to a decrease
in lysosomal calcium and degeneration of sensory neurons in dSap-r
mutants, which leads to physiological deterioration. Therapeutic inter-
ventions to increase cytosolic calcium levels in saposin-deﬁcient pa-
tients may provide a successful route for ameliorating these disorders.
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